These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Congestive heart failure caused by oral disopyramide. Podrid PJ; Schoeneberger A; Lown B N Engl J Med; 1980 Mar; 302(11):614-7. PubMed ID: 7351909 [No Abstract] [Full Text] [Related]
11. Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia. Hayashi Y; Ikeda U; Hashimoto T; Watanabe T; Mitsuhashi T; Shimada K Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):672-4. PubMed ID: 10234723 [TBL] [Abstract][Full Text] [Related]
12. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide. Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233 [TBL] [Abstract][Full Text] [Related]
13. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. Jennings G; Jones MS; Besterman EM; Model DG; Turner PP; Kidner PH Lancet; 1976 Jan; 1(7950):51-4. PubMed ID: 54578 [TBL] [Abstract][Full Text] [Related]
14. The antiarrhythmic effect of intravenous disopyramide in an open study. Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238 [TBL] [Abstract][Full Text] [Related]
15. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide. Commerford PJ; Beck W S Afr Med J; 1980 Sep; 58(11):447-8. PubMed ID: 7404173 [TBL] [Abstract][Full Text] [Related]
16. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction. Rønnevik PK; Gundersen T; Abrahamsen AM Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718 [TBL] [Abstract][Full Text] [Related]
17. Use of radionuclide ventriculography for assessment of changes in myocardial performance induced by disopyramide phosphate. Kowey PR; Friedman PL; Podrid PJ; Zielonka J; Lown B; Wynne J; Holman BL Am Heart J; 1982 Oct; 104(4 Pt 1):769-74. PubMed ID: 6812403 [TBL] [Abstract][Full Text] [Related]
18. Adverse reaction to disopyramide. Dibble JB; Webster NR Postgrad Med J; 1979 Sep; 55(646):570-2. PubMed ID: 514940 [TBL] [Abstract][Full Text] [Related]
19. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine. Wald RW; Waxman MB; Colman JM J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. Vismara LA; Vera Z; Miller RR; Mason DT Am J Cardiol; 1977 Jun; 39(7):1027-34. PubMed ID: 326016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]